GEOGRAPHICAL DISTRIBUTION OF HEPATITIS C VIRUS GENOTYPES IN INDIA AND CURRENT RATIONAL FOR TESTING

Biotechnology

Infection with the hepatitis C virus (HCV), which has a wide geographic and genotypic distribution, is a serious public health problem in India. In this study, we explore the present justification for testing in this varied and dynamic environment and give an overview of the regional distribution of HCV genotypes in India. Geographical Distribution: India is a large and varied country, and various areas have distinct prevalence rates for HCV infection. In India, the regional distribution of HCV genotypes reveals a complicated pattern.The most frequent genotype is genotype 3, which is concentrated in the country's northern and eastern areas. Genotype 1 is more widespread in the country's western and southern regions. In India, genotype 2 and other less frequent genotypes are sporadically seen. This variety in genotypic distribution may influence treatment choices and emphasizes the importance of precise genotype testing prior to starting medication. The present justification for HCV testing in India is complex. The HCV genotype has a significant impact on the direct-acting antiviral (DAA) medication selection.While genotypes 2 and 3 require a distinct mix of DAAs, genotype 1 and genotype 4 are often treated with a single batch of DAAs. To choose the best treatment plan and avoid medication resistance, accurate genotype identification is essential. For public health initiatives, understanding the genotype distribution is crucial. It assists in monitoring the virus's transmission, identifying areas at high risk, and developing preventative measures.. Different genotypes transmit information at different rates. To avoid the spread of the virus through blood transfusions, blood banks and transfusion services must test donors for HCV. In this situation, genotype information is essential. Genotype testing is crucial to determining if resistance-associated variations are to blame in cases of treatment failure. The choice of alternative treatment choices is influenced by this knowledge.In conclusion, India has a broad and regionally distinct distribution of HCV genotypes. For the purpose of making treatment decisions, developing public health plans, preventing the spread of viruses, and tackling antiviral resistance, accurate genotyping testing is essential. To successfully reduce the prevalence of HCV infection in India, it is crucial to understand the significance of genotype-specific management.

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.